Navigation Links
InstaCare Corp. to Announce Guidance on Its Genstrip Product Line on January 10, 2011

NEW YORK, Dec. 30, 2010 /PRNewswire-FirstCall/ -- InstaCare Corp. (OTC Bulletin Board: ISCR),  the exclusive distributor of the Shasta Genstrip diagnostic testing strips, a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill, as well as leading fulfillment provider of direct to patient diabetes programs, and a developer of revolutionary cell phone centric e-health products and technologies, today announced that the company's Board of Directors will, during the month of January 2011, release Guidance for fiscal year 2011.  On January 10, 2011, a preliminary Guidance release will highlight financial information related to its new at-home diagnostic product, the Shasta Genstrip.  

A more comprehensive Guidance release will be issued on January 24, 2011. A shareholder conference call is also planned following the January 24 Guidance release. The details of the shareholder call, including call-in information, will be made available on our website,

Robert Jagunich, Chairman of InstaCare Corp., noted enthusiastically, "These Guidance releases, to be evaluated by an independent financial analyst prior to their release, should communicate the basis of our internal optimism and our confidence in InstaCare's business and revenue models. We believe that our shareholders and the investment community will be impressed with our financial and marketing plan for 2011 and our strategic long term vision. InstaCare will be forecasting, for the first time, the depth and breadth of the financial opportunity that is represented by our new at-home diagnostic testing product, Shasta Genstrip."

For more information about InstaCare Corp. the Shasta Genstrip or its revolutionary MD@Hand cell phone centric technologies, please visit the InstaCare web site or call the company at (805) 446-2973.

Forward Looking Statements:

Forward looking statements are statements made herein which do not address historical facts and, therefore could be interpreted to be forward-looking statements.  We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.  Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The forward-looking statements included in this press release represent our views as of December 30, 2010. We anticipate that subsequent events and developments may cause our views to change.

SOURCE InstaCare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
2. Instacare Corp. Board of Directors Sets Growth Plans for 2010
3. Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
6. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
9. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
Post Your Comments:
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology:
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):